Core Scientific, Inc.
CORZQ
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 101.93M | 116.67M | 119.30M | 118.77M | 112.07M |
| Total Other Revenue | 408.74M | 441.01M | 455.93M | 442.27M | 390.33M |
| Total Revenue | 510.67M | 557.68M | 575.23M | 561.04M | 502.40M |
| Cost of Revenue | 377.37M | 394.14M | 400.95M | 391.71M | 378.94M |
| Gross Profit | 133.30M | 163.54M | 174.28M | 169.32M | 123.46M |
| SG&A Expenses | 132.65M | 117.89M | 100.11M | 93.28M | 100.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.81M | 6.93M | 7.04M | 6.11M | 4.43M |
| Total Operating Expenses | 525.66M | 527.65M | 516.20M | 498.67M | 491.48M |
| Operating Income | -14.99M | 30.02M | 59.03M | 62.36M | 10.92M |
| Income Before Tax | -1.31B | -1.24B | -830.24M | -34.62M | -245.80M |
| Income Tax Expenses | 859.00K | 820.00K | 800.00K | 785.00K | 683.00K |
| Earnings from Continuing Operations | -1.32K | -1.25K | -831.04 | -35.41 | -246.49 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.32B | -1.25B | -831.04M | -35.41M | -246.49M |
| EBIT | -14.99M | 30.02M | 59.03M | 62.36M | 10.92M |
| EBITDA | 98.22M | 148.39M | 172.94M | 167.27M | 106.92M |
| EPS Basic | -5.37 | -5.28 | -4.21 | 0.27 | -0.64 |
| Normalized Basic EPS | -4.06 | -3.64 | -2.69 | 0.14 | -0.12 |
| EPS Diluted | -5.51 | -5.42 | -4.36 | 0.13 | -0.65 |
| Normalized Diluted EPS | -4.11 | -3.69 | -2.74 | 0.09 | -0.12 |
| Average Basic Shares Outstanding | 1.01B | 1.09B | 1.18B | 1.37B | 1.52B |
| Average Diluted Shares Outstanding | 1.06B | 1.14B | 1.23B | 1.43B | 1.52B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
